Lowenthal R M, Marsden K A, Newman N M, Baikie M J, Campbell S N
Aust N Z J Med. 1978 Aug;8(4):431-2. doi: 10.1111/j.1445-5994.1978.tb04918.x.
Daunorubicin, thioguanine and cytosine arabinoside were administered from the 17th to 34th weeks of pregnancy in a 23-year-old patient with acute myeloid leukaemia. The patient went into remission of her leukaemia, and a normal male infant was born after labour was induced in the 40th week. This experience supports the view that modern regimens of anti-leukaemic drugs may be administered during the second and third trimesters of pregnancy without harmful effects on the foetus.
一名23岁的急性髓系白血病患者在怀孕第17至34周期间接受了柔红霉素、硫鸟嘌呤和阿糖胞苷的治疗。患者的白血病进入缓解期，在第40周引产分娩后，一名正常男婴出生。这一经验支持了这样一种观点，即在妊娠中期和晚期可以使用现代抗白血病药物方案，而不会对胎儿产生有害影响。
